Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDF
0
Canada
0
South Africa
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 5-(carboxyethylcarbamoyl-4-phenylazo)salicylic Acid
2. Balsalazide
3. Balsalazine
4. Bx 661a
5. Bx661a
6. Colazal
7. Colazide
1. Colazal
2. 213594-60-6
3. 82101-18-6
4. Balsalazide Sodium
5. Colazide
6. Bx-661a
7. Balsalazidedisodium
8. Balsalazide Disodium Anhydrous
9. 15asw03c9s
10. Balsalazide Disodium Salt Hydrate
11. Giazo
12. Disodium;3-[[4-[(3-carboxy-4-oxidophenyl)diazenyl]benzoyl]amino]propanoate
13. Balsalazine
14. Balsalazide Disodium [usan]
15. Bx 661a
16. Nsc-760046
17. Balzide
18. Balsalazide Disodium Salt
19. Unii-15asw03c9s
20. Schembl30360
21. Schembl3666408
22. Chembl1200760
23. Hms2097a22
24. Hms3264m06
25. Hms3714a22
26. Balsalazide Sodium [who-dd]
27. Akos015896484
28. Akos025294907
29. Ccg-213078
30. Benzoic Acid, 5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-, Disodium Salt
31. Disodium 5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoate
32. Disodium 3-[[4-[(2-carboxylatoethylamino)-oxomethyl]phenyl]hydrazinylidene]-6-oxo-1-cyclohexa-1,4-dienecarboxylate
33. Ft-0622551
34. Ft-0658348
35. Balsalazide Disodium Salt Anhydrous [mi]
36. A815288
37. J-014008
38. Q27251713
39. 5-[4-(2-carboxyethylcarbamoyl)phenylazo]salicylic Acid Disodium Salt
40. Sodium (e)-5-((4-((2-carboxylatoethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoate
41. Sodium(e)-5-((4-((2-carboxylatoethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoate
42. 5-[(1e)-[4-[[(2-carboxyethyl)amino]carbonyl]phenyl]azo]-2-hydroxybenzoic Acid Disodium Salt
43. Benzoic Acid, 5-((1e)-(4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-, Disodium Salt
44. Benzoic Acid, 5-((1e)-2-(4-(((2-carboxyethyl)amino)carbonyl)phenyl)diazenyl)-2-hydroxy-, Sodium Salt (1:2)
45. Disodium 3-[[4-[(3-oxidanidyl-3-oxidanylidene-propyl)carbamoyl]phenyl]hydrazinylidene]-6-oxidanylidene-cyclohexa-1,4-diene-1-carboxylate
46. Disodium,(3z)-3-[[4-(2-carboxylatoethylcarbamoyl)phenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylate
Molecular Weight | 401.28 g/mol |
---|---|
Molecular Formula | C17H13N3Na2O6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 401.05997371 g/mol |
Monoisotopic Mass | 401.05997371 g/mol |
Topological Polar Surface Area | 154 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 539 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Balsalazide Disodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Balsalazide Disodium, including repackagers and relabelers. The FDA regulates Balsalazide Disodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Balsalazide Disodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Balsalazide Disodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Balsalazide Disodium supplier is an individual or a company that provides Balsalazide Disodium active pharmaceutical ingredient (API) or Balsalazide Disodium finished formulations upon request. The Balsalazide Disodium suppliers may include Balsalazide Disodium API manufacturers, exporters, distributors and traders.
click here to find a list of Balsalazide Disodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Balsalazide Disodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Balsalazide Disodium active pharmaceutical ingredient (API) in detail. Different forms of Balsalazide Disodium DMFs exist exist since differing nations have different regulations, such as Balsalazide Disodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Balsalazide Disodium DMF submitted to regulatory agencies in the US is known as a USDMF. Balsalazide Disodium USDMF includes data on Balsalazide Disodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Balsalazide Disodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Balsalazide Disodium suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Balsalazide Disodium Drug Master File in Korea (Balsalazide Disodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Balsalazide Disodium. The MFDS reviews the Balsalazide Disodium KDMF as part of the drug registration process and uses the information provided in the Balsalazide Disodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Balsalazide Disodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Balsalazide Disodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Balsalazide Disodium suppliers with KDMF on PharmaCompass.
A Balsalazide Disodium written confirmation (Balsalazide Disodium WC) is an official document issued by a regulatory agency to a Balsalazide Disodium manufacturer, verifying that the manufacturing facility of a Balsalazide Disodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Balsalazide Disodium APIs or Balsalazide Disodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Balsalazide Disodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Balsalazide Disodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Balsalazide Disodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Balsalazide Disodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Balsalazide Disodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Balsalazide Disodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Balsalazide Disodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Balsalazide Disodium suppliers with NDC on PharmaCompass.
Balsalazide Disodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Balsalazide Disodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Balsalazide Disodium GMP manufacturer or Balsalazide Disodium GMP API supplier for your needs.
A Balsalazide Disodium CoA (Certificate of Analysis) is a formal document that attests to Balsalazide Disodium's compliance with Balsalazide Disodium specifications and serves as a tool for batch-level quality control.
Balsalazide Disodium CoA mostly includes findings from lab analyses of a specific batch. For each Balsalazide Disodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Balsalazide Disodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Balsalazide Disodium EP), Balsalazide Disodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Balsalazide Disodium USP).
LOOKING FOR A SUPPLIER?